Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion type Assertion NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_head.
- NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_provenance.
- NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion evidence source_evidence_literature NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_provenance.
- NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion SIO_000772 17188151 NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_provenance.
- NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion wasDerivedFrom befree-2016 NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_provenance.
- NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion wasGeneratedBy ECO_0000203 NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_provenance.